Replies to post #4592 on Ariad Pharmaceuticals Inc fka ARIA

[BTH]

This is a pretty brutal assessment of Ridaforolimus if you ask me. The JEFFCO analyst is essentially saying that the whole of the company currently is being valued on Ponatinib, lol.

~6 weeks PFS? If that's the case, good luck with Rida in Sarcoma.

[JJM760]

It's not too late for you to start waving the BULL FLAG!

[poorgradstudent]

I think it's pretty silly to say that it could hit the PFS endpoint and not get approval because the delta isn't large enough.

Tarceva is on the market with PFS improvements of well under 6 weeks.